From: Post COVID-19 syndrome in a prospective cohort study of Egyptian patients
Ā | PCFS post (1.5 months) | Chi-square test | |||
---|---|---|---|---|---|
No | Yes | ||||
N (row %) | N (row %) | X2 | p value | Sig. | |
Severity | |||||
āMild | 59 (62.1%) | 36 (37.9%) | 67.814 | < 0.001 | S |
āModerate | 1 (2.1%) | 46 (97.9%) | |||
āSevere | 0 (0.0%) | 28 (100.0%) | |||
Post COVID-19 symptoms | |||||
āNo | 50 (83.33%) | 56 (50.91%) | 17.388 | < 0.001 | S |
āYes | 10 (16.67%) | 54 (49.09%) |